Your browser doesn't support javascript.
loading
Administration of 4­hexylresorcinol increases p53­mediated transcriptional activity in oral cancer cells with the p53 mutation.
Kang, Yei-Jin; Yang, Won-Geun; Chae, Weon-Sik; Kim, Dae-Won; Kim, Seong-Gon; Rotaru, Horatiu.
Afiliación
  • Kang YJ; Department of Oral and Maxillofacial Surgery, Gangneung­Wonju National University, Gangneung, Gangwon-do 25457, Republic of Korea.
  • Yang WG; Daegu Center, Korea Basic Science Institute, Daegu 41566, Republic of Korea.
  • Chae WS; Daegu Center, Korea Basic Science Institute, Daegu 41566, Republic of Korea.
  • Kim DW; Department of Oral Biochemistry, College of Dentistry, Gangneung­Wonju National University, Gangneung, Gangwon-do 25457, Republic of Korea.
  • Kim SG; Department of Oral and Maxillofacial Surgery, Gangneung­Wonju National University, Gangneung, Gangwon-do 25457, Republic of Korea.
  • Rotaru H; Department of Cranio­Maxillofacial Surgery, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj­Napoca 400000, Romania.
Oncol Rep ; 48(3)2022 Sep.
Article en En | MEDLINE | ID: mdl-35856441
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma / Hexilresorcinol Límite: Humans Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma / Hexilresorcinol Límite: Humans Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article